Edition:
India

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$0.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,960
52-wk High
$3.38
52-wk Low
$0.60

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.17 December 22 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2 1.16 1.23 1.10 2.80
Quarter Ending Mar-18 1 1.20 1.20 1.20 --
Year Ending Dec-17 2 5.25 5.30 5.20 8.51
Year Ending Dec-18 2 8.82 10.15 7.50 12.02
Earnings (per share)
Quarter Ending Dec-17 2 -0.17 -0.14 -0.19 -0.33
Quarter Ending Mar-18 1 -0.14 -0.14 -0.14 --
Year Ending Dec-17 2 -0.76 -0.72 -0.80 -1.49
Year Ending Dec-18 2 -0.51 -0.42 -0.60 -1.77

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.50 1.11 0.38 25.69
Quarter Ending Jun-17 1.33 1.28 0.05 3.74
Quarter Ending Mar-17 1.32 1.68 0.36 27.60
Quarter Ending Dec-16 1.26 1.29 0.04 2.91
Quarter Ending Sep-16 0.76 1.05 0.29 38.13

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.16 1.61 1.64 1.64 2.80
Quarter Ending Mar-18 1.20 1.70 1.62 1.62 --
Year Ending Dec-17 5.25 5.95 6.08 6.08 8.51
Year Ending Dec-18 8.82 10.02 9.13 9.13 12.02

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 1 0 2
Quarter Ending Mar-18 0 1 0 1
Year Ending Dec-17 0 1 0 2
Year Ending Dec-18 0 1 0 2
Earnings